Oral vs. Injectable Hormone Blockers for IVF/ICSI
Part of Women’s health & pregnancy clinical trials.
This study tests an oral medication (linzagolix) versus an injectable medication commonly used to control the timing of ovulation during IVF or ICSI. The goal is to see if the oral option works as well as the injection, making treatment simpler for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 42 years old.
- You are planning to have IVF or ICSI with controlled ovarian stimulation at CENTRO AMBRA.
- You are willing to be randomly assigned to either the oral medication (linzagolix) or the injectable medication (GnRH antagonist).
- You do not have any known allergies or health conditions that would make the study drugs unsafe.
- You do not have uterine abnormalities (like certain fibroids or shape issues) that could affect the results.
- You are not currently participating in another interventional clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if linzagolix can help women with adenomyosis who have had two or more failed embryo transfers. It aims to improve the chance of a successful pregnancy in a future transfer.
This trial tests if combining two fertility medications (letrozole and clomiphene citrate) works better than using letrozole alone to help women with ovulation problems release an egg. The goal is to find a more effective treatment for women trying to conceive.
This study compares two ways to prepare the ovaries for egg retrieval before IVF: using a progestin hormone or a GnRH antagonist. The goal is to see which method leads to more successful embryo transfers.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
This trial compares two different medications (Prolutex or Cetrotide) used during a freeze-all IVF cycle to prevent early ovulation. The goal is to see which medication works better for women who are at risk of ovarian hyperstimulation syndrome, need genetic testing, or choose to freeze all embryos for personal reasons.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.